GO:1990089 response to nerve growth factor: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990089 (response to nerve growth factor) is a biological process describing any change in cell or organism state caused by a nerve growth factor (NGF) stimulus.
• NGF responses span neuronal survival, differentiation, inflammatory cytokine release, and tumor drug resistance, making the term relevant to neuroscience, oncology, and immunology.
• The NGF receptor system (NTRK1/TrkA, NGFR/p75NTR) and downstream effectors such as MAPK, PI3K, and PLC-gamma are central to this process.
• NGF signaling can drive lenvatinib resistance in hepatocellular carcinoma, linking this GO term to cancer therapy.
• NGF is also implicated in bone repair, cavernous nerve injury, Alzheimer's disease amyloid pathology, and stress resilience.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect causal roles of NGF pathway genes in these diverse contexts.
Description
GO:1990089, response to nerve growth factor, is a Gene Ontology biological process that captures any change in a cell or organism's state or activity following a nerve growth factor (NGF) stimulus. NGF is a neurotrophic factor best known for its roles in neuronal survival, differentiation, and plasticity, but its effects extend to immune cells, bone, and cancer cells. The term encompasses movement, secretion, enzyme production, and gene expression changes triggered by NGF. Researchers study this process to understand neurodevelopment, nerve injury repair, inflammation, and tumor biology. Because NGF responses are highly context-dependent, reproducible experimental models are critical. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:1990089, its mechanisms, key genes, disease links, and CRISPR-based methods for functional dissection.
response to nerve growth factor At A Glance
| GO ID | GO:1990089 |
|---|---|
| GO term | response to nerve growth factor |
| Ontology | biological_process |
| Synonym | response to nerve growth factor stimulus |
| Major function | Mediates cellular and organismal changes triggered by NGF, including survival, differentiation, secretion, and gene expression |
| Key receptors | NTRK1 (TrkA) and NGFR (p75NTR) |
| Downstream pathways | MAPK/ERK, PI3K/AKT, PLC-gamma |
| Disease relevance | Cancer drug resistance, neurodegeneration, bone repair, inflammation |
| Research models | PC12 cells, knockout mice, gene delivery, nanofiber release systems |
What Is GO:1990089?
According to QuickGO, GO:1990089 (response to nerve growth factor) is defined as a process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nerve growth factor stimulus. The synonym is response to nerve growth factor stimulus. In practice, this means any measurable cellular or physiological output triggered by NGF binding to its receptors, including survival, differentiation, cytokine release, and metabolic shifts.
Why Is response to nerve growth factor Important in Cell Biology?
GO:1990089 is important because NGF responses influence fundamental processes such as neuronal survival, immune modulation, bone repair, and cancer therapy resistance. Understanding this process helps researchers identify therapeutic targets and biomarkers across neurology, oncology, and regenerative medicine.
• NGF signaling limits the response to lenvatinib in hepatocellular carcinoma, directly linking GO:1990089 to cancer drug resistance.
• NGF is involved in reparative reactions to osteonecrotic lesions, highlighting its role in bone biology.
• NGF modulates the cavernous nerve response to injury, relevant to erectile dysfunction and nerve regeneration.
• NGF gene delivery across the blood-brain barrier reduces beta amyloid accumulation in Alzheimer's disease models.
• NGF and its carrier protein affect inflammatory responses from human monocytes.
• Salivary NGF response to stress is related to resilience, linking this process to behavioral physiology.
• PC12 cell responses to NGF vary across laboratories, raising reproducibility concerns for tumor cell line studies.
• Enzyme-mediated NGF release from nanofibers using gelatin microspheres offers controlled delivery for tissue engineering.
What Happens During response to nerve growth factor?
NGF Binding and Receptor Activation
In simple terms: NGF binds to receptors on the cell surface, switching them on.
The response begins when NGF binds to its high-affinity receptor NTRK1 (TrkA) or the low-affinity receptor NGFR (p75NTR). This binding triggers receptor dimerization and autophosphorylation, initiating intracellular signaling cascades. In PC12 cells, the heterogeneity of response to NGF across laboratories underscores the importance of standardized receptor activation assays.
Downstream Signaling Cascades
In simple terms: Activated receptors turn on a chain of signaling proteins inside the cell.
Activated TrkA recruits adaptor proteins and activates MAPK/ERK, PI3K/AKT, and PLC-gamma pathways. These cascades lead to changes in gene expression, enzyme production, and secretion. In hepatocellular carcinoma, activation of NGF signaling limits the response to lenvatinib, demonstrating the clinical impact of these cascades.
Cellular and Physiological Outputs
In simple terms: The signaling leads to visible changes in the cell or organism.
NGF responses include neuronal survival, differentiation, inflammatory cytokine release, and metabolic changes. In bone, NGF is involved in reparative reactions to osteonecrotic lesions. In human monocytes, NGF and its carrier protein modulate inflammatory responses. Salivary NGF levels change in response to stress and correlate with resilience.
Therapeutic and Delivery Considerations
In simple terms: How NGF is delivered affects the response.
NGF gene delivery across the blood-brain barrier reduces beta amyloid accumulation in Alzheimer's disease mice. Enzyme-mediated NGF release from nanofibers using gelatin microspheres provides controlled delivery for tissue engineering. These approaches highlight the importance of delivery systems in modulating GO:1990089.
Key Genes Involved in GO:1990089 response to nerve growth factor
The following genes and proteins are central to the response to nerve growth factor (GO:1990089), based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NGF | Ligand that initiates the response | Central to all NGF response studies |
| NTRK1 (TrkA) | High-affinity NGF receptor | Mediates survival and differentiation signaling |
| NGFR (p75NTR) | Low-affinity NGF receptor | Modulates neuronal and immune responses |
| MAPK1/3 (ERK) | Downstream kinase in MAPK pathway | Key effector of NGF-induced gene expression |
| PIK3CA/AKT | PI3K/AKT pathway components | Promote survival and metabolic changes |
| PLCG1 | Phospholipase C gamma | Mediates calcium and PKC signaling |
| RAS | Small GTPase upstream of MAPK | Activates ERK cascade upon NGF stimulation |
| SRC | Non-receptor tyrosine kinase | Contributes to NGF signaling diversity |
| CASP3 | Apoptosis effector | Balances survival vs. death in NGF responses |
| BDNF | Related neurotrophin | Cross-talk with NGF pathways |
| APP | Amyloid precursor protein | Linked to NGF effects on beta amyloid |
| IL6 | Inflammatory cytokine | Modulated by NGF in monocytes |
| TNF | Inflammatory cytokine | Affected by NGF and carrier protein |
| MMP9 | Matrix metalloproteinase | Involved in nerve injury repair |
| COL1A1 | Collagen type I | Bone repair response to NGF |
| BGLAP | Osteocalcin | Bone formation marker in NGF studies |
| VEGFA | Angiogenesis factor | Linked to NGF in tumor microenvironment |
How Is response to nerve growth factor Regulated?
The response to nerve growth factor is regulated at multiple levels. Receptor availability and trafficking modulate sensitivity to NGF. Downstream feedback loops in MAPK and PI3K pathways fine-tune the duration and magnitude of signaling. In inflammatory contexts, carrier proteins can modulate NGF's effects on monocytes. Stress-related changes in salivary NGF suggest systemic regulation. Delivery systems such as nanofibers can control the spatiotemporal availability of NGF.
response to nerve growth factor and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NGF | Hepatocellular carcinoma drug resistance | Knockout of NGF in HCC cell lines |
| NTRK1 | Neurodegeneration | Knock-in of TrkA variants in mice |
| NGFR | Inflammation | Overexpression in monocytes |
| NGF | Osteonecrosis | Knockout mice with bone injury |
| NGF | Stress resilience | Point mutation in NGF regulatory regions |
Cancer Drug Resistance
Activation of NGF signaling limits the response to lenvatinib in hepatocellular carcinoma, suggesting that targeting this pathway could overcome resistance. This links GO:1990089 directly to cancer therapy outcomes.
Neurodegeneration
NGF gene delivery across the blood-brain barrier reduces beta amyloid accumulation in Alzheimer's disease mice, indicating a protective role for NGF responses in neurodegeneration.
Bone and Nerve Injury
NGF is involved in reparative reactions to osteonecrotic lesions and modulates the cavernous nerve response to injury, highlighting its role in tissue repair.
Inflammation and Stress
NGF and its carrier protein affect inflammatory responses from human monocytes, and salivary NGF response to stress is related to resilience. These findings connect GO:1990089 to immune and behavioral physiology.
From response to nerve growth factor-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NGF drive lenvatinib resistance? | NGF knockout in hepatocellular carcinoma cells |
| How does NGF affect bone repair? | NGF knockout mice with osteonecrotic lesions |
| Can NGF gene delivery reduce amyloid? | Knock-in of NGF in AD mouse models |
| What is the role of TrkA in NGF response? | Point mutation in NTRK1 kinase domain |
| How does NGF affect monocyte inflammation? | Overexpression of NGF in human monocytes |
| Can controlled NGF release improve tissue engineering? | Tagged knock-in of NGF for tracking |
How to Study the response to nerve growth factor Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify NGF-induced transcripts |
| Proteomics | Protein abundance and modifications | Map signaling cascades |
| Live-cell imaging | Receptor dynamics | Visualize NGF binding and internalization |
| Cytokine assays | Inflammatory mediator release | Measure monocyte responses |
| Survival assays | Cell viability | Assess neurotrophic effects |
| Differentiation assays | Neurite outgrowth | PC12 cell response |
| Gene delivery | In vivo NGF expression | Blood-brain barrier crossing |
| Nanofiber release | Controlled NGF delivery | Tissue engineering |
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics can identify gene expression and protein changes following NGF stimulation, revealing downstream effectors of GO:1990089.
Imaging and Live-Cell Assays
Fluorescence imaging of receptor trafficking and signaling dynamics helps visualize NGF responses in real time.
Functional Assays
Survival, differentiation, and cytokine release assays measure physiological outputs of NGF stimulation.
Delivery and Release Studies
Nanofiber-based release systems and gene delivery across the blood-brain barrier test controlled NGF exposure.
How CRISPR Can Be Used to Study GO:1990089 response to nerve growth factor
Knockout
CRISPR knockout of NGF or its receptors (NTRK1, NGFR) can abolish the response to nerve growth factor, providing causal evidence for gene function in models such as hepatocellular carcinoma and bone repair.
Point Mutation
Point mutations in NTRK1 or downstream kinases can dissect specific phosphorylation sites required for NGF signaling, as highlighted by reproducibility studies in PC12 cells.
Knock-in
Knock-in of tagged NGF or reporter alleles allows tracking of NGF expression and release in vivo, useful for Alzheimer's disease and tissue engineering studies.
Overexpression
Overexpression of NGF or its carrier protein in monocytes or cancer cells can model gain-of-function effects on inflammation and drug resistance.
How EDITGENE Supports response to nerve growth factor Research
Researchers studying response to nerve growth factor-related genes often need to determine whether a candidate gene is causally involved in NGF signaling, inflammatory modulation, or tumor drug resistance. EDITGENE provides CRISPR-based cell model services to enable these functional studies.
Contact EDITGENE today to design your custom CRISPR model for response to nerve growth factor research.
Frequently Asked Questions About response to nerve growth factor
What is GO:1990089?
GO:1990089 is the Gene Ontology term for response to nerve growth factor, a biological process describing changes in cell or organism state caused by NGF.
What genes are involved in response to nerve growth factor?
Key genes include NGF, NTRK1 (TrkA), NGFR (p75NTR), MAPK1/3, PIK3CA, AKT, and PLCG1.
How does NGF signaling affect cancer?
Activation of NGF signaling limits the response to lenvatinib in hepatocellular carcinoma, contributing to drug resistance.
Is NGF involved in Alzheimer's disease?
NGF gene delivery across the blood-brain barrier reduces beta amyloid accumulation in AD mice.
What are common research models for NGF response?
PC12 cells, knockout mice, gene delivery systems, and nanofiber release models are commonly used.
How does NGF affect inflammation?
NGF and its carrier protein modulate inflammatory responses from human monocytes.
Can NGF response be measured in saliva?
Yes, salivary NGF response to stress is related to resilience.
What is the role of NGF in bone repair?
NGF is involved in reparative reactions to osteonecrotic lesions.
Why is reproducibility a concern in NGF studies?
PC12 cell responses to NGF vary across laboratories, questioning reproducibility of tumor cell line studies.
How can CRISPR help study NGF response?
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of NGF pathway genes.
Conclusion
GO:1990089 (response to nerve growth factor) is a broad biological process with critical roles in neuronal survival, inflammation, bone repair, and cancer drug resistance. The integration of QuickGO definitions with verified literature provides a solid foundation for functional studies. CRISPR-based models from EDITGENE can accelerate the discovery of causal genes and therapeutic targets within this pathway.
References
- 1. Xu M et al.. 2026. Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma.. Signal Transduct Target Ther 11(1) PMID: 41946693
- 2. Ayabe Y et al.. 2025. Involvement of Nerve Growth Factor in the Reparative Reaction to Osteonecrotic Lesions.. J Orthop Res 43(5):939-948 PMID: 39930333
- 3. Bella AJ et al.. 2009. Nerve growth factor modulation of the cavernous nerve response to injury.. J Sex Med 6 Suppl 3(Suppl 3):347-52 PMID: 19267859
- 4. Rodrigues BDS et al.. 2020. Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.. Mol Pharm 17(6):2054-2063 PMID: 32315185
- 5. Verres Y et al.. 2024. Effects of the nerve growth factor and its carrier protein on the inflammatory response from human monocytes.. Fundam Clin Pharmacol 38(5):940-945 PMID: 38693600
- 6. Laurent HK et al.. 2014. Salivary nerve growth factor response to stress related to resilience.. Physiol Behav 129:130-4 PMID: 24582676
- 7. Delage C et al.. 2023. The Heterogeneity of Response of PC12 Cells from Different Laboratories to Nerve Growth Factor and Pituitary Adenylate Cyclase-Activating Polypeptide Questions the Reproducibility of Studies Carried Out with Tumor Cell Lines.. Neuroendocrinology 113(2):216-230 PMID: 34348336
- 8. Mays EA et al.. 2023. Enzyme-Mediated Nerve Growth Factor Release from Nanofibers Using Gelatin Microspheres.. Tissue Eng Part A 29(11-12):333-343 PMID: 37016821
